Trial intelligence / Profile preview

Levetiracetam to prevent postoperative seizures after meningioma surgery

ISRCTN14381346Phase 3Recruiting

Sponsor
University of Liverpool
Start
Jul 2024
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in epilepsy comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Time to at least one seizure at 12 months post-surgery. Started Jul 2024; status: recruiting.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on ISRCTN14381346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14381346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call